Clearance Summary
QIAstat-Dx Respiratory Panel received FDA 510(k) clearance under submission number K183597, sponsored by QIAGEN GmbH. The device was reviewed via the Traditional premarket notification pathway and assigned to the Microbiology review panel. The statutory decision date of record is 2019-05-18.
- Submission: K183597
- Applicant / Sponsor: QIAGEN GmbH
- Clearance pathway: Traditional
- Review panel: Microbiology
- Device class: Class II
- Regulation citation: 21 CFR 866.3980
- Decision date: 2019-05-18
Classification & Regulation
This clearance is catalogued under FDA product code OCC and 21 CFR 866.3980, within the Microbiology review panel as a Class II device.